Market Closed - Oslo Bors 10:45:00 2024-04-26 am EDT 5-day change 1st Jan Change
2.965 NOK -12.92% Intraday chart for Lifecare -20.62% -33.52%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Lifecare to Take Majority Stake in Medical Technology Company RemovAid MT
Lifecare Seeks Fresh Capital from Rights Offering MT
Evexia Lifecare Gets Board Nod to Acquire 80% of Revin Labs for INR448 Million MT
Vikas Lifecare's Agro Division Secures Order Worth INR110 Million MT
Vikas Lifecare Bags INR110 Million Orders for Premium Nuts MT
Vikas Lifecare Bags INR500 Million Order for Rice; Shares Climb 3% MT
Vikas Lifecare to Acquire 7.5% Stake in Indian News Channel For INR150 Million MT
Lifecare AS Announces European Patent Office Grants for New Lifecare Patent CI
Vikas Lifecare Secures New Patent in India; Shares Drop 3% MT
Remedium Lifecare Bags Export Order Worth INR1.69 Billion MT
Lifecare AS Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Lifecare AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Remedium Lifecare Plans to Buy Factory in Hyderabad, India MT
Lifecare to Move Listing to Oslo Bourse MT
Vikas Lifecare Purchases Land in West Delhi for New Office MT
Vikas Lifecare Names CEO, COO MT
Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024 CI
Lifecare Appoints Grieg Seafood Executive as CFO MT
Vikas Lifecare to Acquire 60% Stake in Dubai Night Club for $79 Million MT
Vikas Lifecare Acquires 50% Stake in Dubai-Based Events Management Firm MT
Vikas Lifecare Arm Incorporates Joint Venture with Indraprastha Gas MT
Remedium Lifecare Gets Board Nod for Stock Split MT
Vikas Lifecare Buys Land in Rajasthan, India, for Polymer and Rubber Business Expansion MT
Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board CI
Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare MT
Chart Lifecare
More charts
Lifecare AS is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Calendar
More about the company

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. LIFE Stock
  4. News Lifecare
  5. Lifecare : Jumps 36% After Landing Germany's OK for First-In-Human Sencell Senor Study for Glucose Measurement